US

Celonis rakes in about $290 mln Series C

Munich and New York-based Celonis, a provider of process mining and process excellence software, has raised approximately $290 million in Series C funding. Arena Holdings led the round.

Silofit pulls in seed funding

Montreal-based Silofit, a network of private fitness spaces, has secured C$1 million in seed funding. Whitecap Venture Partners and Courtside Ventures led the round with participation from NFL player Ndamukong Suh. The capital will be used for expansion, personnel hiring and adding new facilities to its portfolio.

BDC Capital invests in Lube City

BDC Capital's growth equity group has invested in a family ownership change for Edmonton, Alberta-based Lube City Corp, a provider of quick service oil changes. No financial terms were disclosed.

Founders First racks up $100 mln

San Diego-based Founders First Capital Partners, a provider of funding and business acceleration support to service-based small businesses, has secured $100 million in debt funding. The investor was Community Investment Management.

AN2 Therapeutics scores $12 mln Series A

California-based AN2 Therapeutics Inc, a biopharmaceutical company focused on infectious diseases, has raised $12 million in Series A financing. Mountain Group Partners led the round with participation from Adjuvant Capital, Brii Biosciences and BioRock Ventures.

Shasta Ventures leads $17 mln round for Banyan Security

Banyan Security, a provider of cloud-centric secure remote access solutions, has raised $17 million in funding. Shasta Ventures led the round with participation from Unusual Ventures.

GuardRails snags $750K seed

Singapore-based GuardRails, a SaaS-based software security provider, has secured $750,000 in seed financing. Cocoon Capital led the round.

Base picks up $2.6 mln seed

Greenville, South Carolina-based Base, a SaaS platform built for executive assistants, has secured $2.6 million in seed funding. Matchstick Ventures led the round with participation from Revolution’s Rise of the Rest Seed Fund, High Alpha Capital and Slack Fund.

Immunitas Therapeutics nets $39 mln Series A

Cambridge, Massachusetts-based Immunitas Therapeutics, a single cell genomics-based drug discovery company founded by Longwood Fund, has secured $39 million in Series A financing. Leaps by Bayer and Novartis Venture Fund led the round.

Genesis Therapeutics takes in $4.1 mln seed

South San Francisco-based Genesis Therapeutics, a biotech company, has raised $4.1 million in seed funding. Andreessen Horowitz led the round with participation from Felicis Ventures.